|
|
 |
|
Viewing report
|
|
|
|
The Top 100 In Vitro Diagnostics Manufacturing Companies in Europe
Research Facts Ltd, Jan 2003, Pages: 122
The global IVD market is worth an estimated EUR 19.5 billion, broken down as follows:
Sector [EUR, million]
Clinical Chemistry 5,271
Infectious Diseases 5,627
Rapid TestsCoagulationEndocrine TestingGlucose 4,209
Haematology 1,253
Blood Grouping/Typing
The largest IVD segments are infectious diseases, clinical chemistry and glucose. Glucose and rapid tests are the fastest growing.
It is anticipated that the IVD market in Western Europe will grow at a rate of 5% per annum. Within this region, Germany has the biggest market share with sales of almost Euro 1.6 billion which accounts for 24% of the total European market. Italy has the next highest sales with revenues of Euro 1.1 billion and 18% of the market. After Italy come France, Spain, United Kingdom, Belgium and Switzerland.
This report profiles the Top 100 companies in the In Vitro Diagnostics market.
The Top 100 companies in this report have a combined employment of over 70,000 staff and a combined turnover of just over Euro 10 billion.
Full company profile information for each company, including:
- Full Company Contact Information (Telephone and fax numbers, websites, addresses and headquarters/parent company)
- Key Company Decision Makers - From CEO and Main Board, to Key Senior Managers
- Specialised fields such as Product Descriptions and Product Listings, Turnover, Employment and Year Established
- SIC and Naics Classifications
Report Target Market:
1) IVD Companies
Usage: competitive/financial analysis, partner/alliance identification, and distributor/supplier selection
2) IVD Suppliers
This report is perfect for suppliers to IVD companies who wish to identify top potential customers.
3) IVD Buyers
It is also very useful for hospitals, private and research laboratories, and blood banks to identify suppliers
Companies in this report cover:
- Clinical Chemistry
- Infectious Diseases
- Rapid Tests
- Coagulation
- Endocrine Testing
- Glucose
- Haematology
- Blood Grouping/Typing
- Point of Care
Note: Most companies will be fully aware of the major players in this sector, like Abbott, Roche, etc. but this report looks at all 100 of the top companies in the sector
Report data field structure is as follows:
- Company Name
- Company Address
- Company Phone
- Company Fax
- Company Web Address
- Parent Company
- Parent Company Phone
- Employment (Individual site/All sites)
- Top Executives
- SIC Code(s)
- Naics Code(s)
- Product(s)
- Location Status
- Turnover €m
- Year Established
- Ownership
Research Facts Reports help you make informed decisions about the markets and firms that affect your business.
- Learn more about your target markets, and target companies
- Top level research on all 100 major players in a market
- See which companies dominate your major markets
- Get detailed information on particular companies
Formats:
Hardcopy: Bound report, A4 format, 122 pages
Electronic:.pdf Version, A4 format, 122 pages
Site License Version: Allows you to post this report on your Intranet/Knowledge Management System, to allow all employees at your organisation to access the report electronically.
Mailing List Version: The Mailing List Version allows you to download a CSV table of all 100 companies into your internal databases and/or spreadsheets.
Customers who bought this item also bought
The Top 30 Manufacturers In Europe Of IVD For Haematology & Coagulation Testing
The Future of the In-Vitro Diagnostics Market to 2016 - Increasing Diagnostic Procedures Drive Demand
The Top 20 Manufacturers In Europe Of Clinical Chemistry Analyzers & Reagents
In-vitro Diagnostics Market Outlook in Taiwan
Point of Care Testing: Evaluating the Return to Evidence Based Medicine, Novel Technologies and the Competitive Landscape
The Top 60 Manufacturers Worldwide Of IVD For Infectious Diseases
In-vitro Diagnostics Market Outlook in Australia
The Top 20 Manufacturers Of Point-Of-Care Diagnostics For Haematology & Coagulation Testing
Complete Guide to the Diagnostic Market 2007-2012
Innovations in Diagnostics: Next Generation Molecular and Point-of-Care Diagnostics Driving Personalized Healthcare
|
|
|
|
